100%(12)12 out of 12 people found this document helpful
This preview shows page 4 - 6 out of 6 pages.
interpreted results appropriately. Patients should make well-informed decisions regarding their health care and preventative screening options. Patients should be counseling on the risks and
RUNNING HEAD: Prostate-Specific Antigen 5benefits of prostate cancer screening exam. Educating the patient, especially high-risk patients, on preventative screenings, such as the prostate-specific antigen test, assists them in making educated decisions. Empowering our patients allows for early diagnosis, early treatment, and increased quality of life.References
RUNNING HEAD: Prostate-Specific Antigen 6Adhyam, M., & Gupta, A. K. (2012). A Review on the Clinical Utility of PSA in Cancer Prostate. Indian journal of surgical oncology, 3(2), 120–129. doi:10.1007/s13193-012-0142-6American Cancer Society. (2019). Key Statistics for Prostate Cancer. Retrieved from Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.Chun, C. (2017). What’s Free PSA and How Is It Used to Diagnose Prostate Cancer? Healthline. Retrieved from Dains, J. E., Baumann, L. C., & Scheibel, P. (2019). Advanced health assessment and clinical diagnosis in primary care (6th ed.). St. Louis, MO: Elsevier Mosby.Mayo Clinic. (2018). Prostate Cancer. Retrieved from -conditions/prostate-cancer/symptoms-causes/syc-20353087Prostate Cancer Foundation. (2019). Prostate Cancer Diet. Retrieved from Seaman, A. (2014). Test for prostate cancer 'does more harm than good.’ Irish Examiner. Retrieved from -more-harm-than-good-295479.html